News Image

Molecular Partners to hold three poster presentations at AACR 2025

Provided By GlobeNewswire

Last update: Mar 25, 2025

Update on IND-enabling data for MP0712, a Radio-DARPin targeting DLL3 and labeled with 212Pb, co-developed with Orano Med; entering FIH studies in 2025 for the treatment of small cell lung cancer

Read more at globenewswire.com

MOLECULAR PARTNERS AG -ADR

NASDAQ:MOLN (11/14/2025, 8:06:09 PM)

4.22

-0.06 (-1.4%)



Find more stocks in the Stock Screener

Follow ChartMill for more